US Stock MarketDetailed Quotes

IPSC Century Therapeutics

Watchlist
  • 1.590
  • -0.010-0.63%
Close Sep 16 16:00 ET
134.70MMarket Cap-787P/E (TTM)

Century Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
678.79%771K
-50.29%855K
-57.01%2.24M
-48.56%268K
-93.35%148K
-92.91%99K
62.57%1.72M
5.2M
521K
2.22M
Operating revenue
678.79%771K
-50.29%855K
-57.01%2.24M
-48.56%268K
-93.35%148K
-92.91%99K
62.57%1.72M
--5.2M
--521K
--2.22M
Cost of revenue
Gross profit
Operating expense
14.76%35.53M
-4.84%32.16M
-1.25%127.42M
-8.70%30.89M
-6.44%31.77M
-5.47%30.96M
18.62%33.8M
35.99%129.03M
20.93%33.83M
31.50%33.96M
Selling and administrative expenses
0.94%8.31M
-1.79%8.74M
8.94%34.71M
4.21%8.59M
11.43%8.99M
-0.29%8.23M
21.98%8.9M
65.62%31.86M
33.43%8.24M
28.37%8.06M
-General and administrative expense
0.94%8.31M
-1.79%8.74M
8.94%34.71M
4.21%8.59M
11.43%8.99M
-0.29%8.23M
21.98%8.9M
65.62%31.86M
33.43%8.24M
28.37%8.06M
Research and development costs
19.77%27.22M
-5.94%23.42M
-4.59%92.71M
-12.86%22.3M
-12.01%22.79M
-7.21%22.73M
17.47%24.9M
28.45%97.17M
17.38%25.59M
32.50%25.9M
Operating profit
-12.63%-34.76M
2.41%-31.31M
-1.09%-125.18M
8.07%-30.62M
0.35%-31.63M
1.58%-30.86M
-16.93%-32.08M
-30.51%-123.83M
-19.06%-33.31M
-22.89%-31.74M
Net non-operating interest income expense
22.59%3.58M
45.88%3.24M
305.92%12.14M
114.42%3.51M
235.84%3.49M
677.13%2.92M
3,737.70%2.22M
334.51%2.99M
609.97%1.64M
422.36%1.04M
Non-operating interest income
17.14%3.58M
23.41%3.24M
186.81%12.68M
71.22%3.51M
147.06%3.49M
333.14%3.06M
936.76%2.62M
--4.42M
--2.05M
--1.41M
Non-operating interest expense
--0
--0
-55.00%540K
--0
--0
-46.46%136K
46.22%348K
23.84%1.2M
69.26%413K
20.82%296K
Total other finance cost
----
----
----
----
----
----
-26.32%56K
-24.84%230K
--0
0.00%77K
Other net income (expense)
99.73%-12K
105.67%11K
-117.48%-21.75M
-69,363.16%-13.16M
-16,516.67%-3.99M
-88,220.00%-4.41M
98.06%-194K
-2,752.52%-10M
-86.71%19K
-117.14%-24K
Special income (charges)
--0
----
-113.65%-21.37M
---13.15M
---4M
---4.22M
----
---10M
--0
--0
-Less:Impairment of capital assets
--0
----
--16.37M
--12.15M
--0
--4.22M
----
--0
--0
--0
-Less:Other special charges
----
----
-50.00%5M
--1M
--4M
----
----
--10M
--0
----
Other non- operating income (expenses)
93.55%-12K
105.67%11K
---383K
---15K
150.00%12K
-3,820.00%-186K
---194K
----
----
-117.14%-24K
Income before tax
3.57%-31.19M
6.64%-28.06M
-3.02%-134.79M
-27.23%-40.27M
-4.57%-32.13M
-4.43%-32.34M
19.84%-30.06M
-36.60%-130.84M
-12.43%-31.65M
-18.13%-30.72M
Income tax
-97.68%22K
-99.92%1K
1,967.03%1.88M
-2,815.63%-869K
2,268.00%592K
5,177.78%950K
7,450.00%1.21M
111.63%91K
32K
25K
Net income
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-36.64%-130.93M
-12.37%-31.68M
-18.22%-30.75M
Net income continuous Operations
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-36.64%-130.93M
-12.37%-31.68M
-18.22%-30.75M
Minority interest income
Net income attributable to the parent company
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-36.64%-130.93M
-12.37%-31.68M
-18.22%-30.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-36.64%-130.93M
-12.37%-31.68M
-18.22%-30.75M
Basic earnings per share
32.14%-0.38
15.09%-0.45
-1.32%-2.3
-18.18%-0.65
-3.77%-0.55
-3.70%-0.56
19.70%-0.53
23.31%-2.27
-7.30%-0.55
-10.42%-0.53
Diluted earnings per share
32.14%-0.38
15.09%-0.45
-1.32%-2.3
-18.18%-0.65
-3.77%-0.55
-3.70%-0.56
19.70%-0.53
23.31%-2.27
-7.30%-0.55
-10.42%-0.53
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 678.79%771K-50.29%855K-57.01%2.24M-48.56%268K-93.35%148K-92.91%99K62.57%1.72M5.2M521K2.22M
Operating revenue 678.79%771K-50.29%855K-57.01%2.24M-48.56%268K-93.35%148K-92.91%99K62.57%1.72M--5.2M--521K--2.22M
Cost of revenue
Gross profit
Operating expense 14.76%35.53M-4.84%32.16M-1.25%127.42M-8.70%30.89M-6.44%31.77M-5.47%30.96M18.62%33.8M35.99%129.03M20.93%33.83M31.50%33.96M
Selling and administrative expenses 0.94%8.31M-1.79%8.74M8.94%34.71M4.21%8.59M11.43%8.99M-0.29%8.23M21.98%8.9M65.62%31.86M33.43%8.24M28.37%8.06M
-General and administrative expense 0.94%8.31M-1.79%8.74M8.94%34.71M4.21%8.59M11.43%8.99M-0.29%8.23M21.98%8.9M65.62%31.86M33.43%8.24M28.37%8.06M
Research and development costs 19.77%27.22M-5.94%23.42M-4.59%92.71M-12.86%22.3M-12.01%22.79M-7.21%22.73M17.47%24.9M28.45%97.17M17.38%25.59M32.50%25.9M
Operating profit -12.63%-34.76M2.41%-31.31M-1.09%-125.18M8.07%-30.62M0.35%-31.63M1.58%-30.86M-16.93%-32.08M-30.51%-123.83M-19.06%-33.31M-22.89%-31.74M
Net non-operating interest income expense 22.59%3.58M45.88%3.24M305.92%12.14M114.42%3.51M235.84%3.49M677.13%2.92M3,737.70%2.22M334.51%2.99M609.97%1.64M422.36%1.04M
Non-operating interest income 17.14%3.58M23.41%3.24M186.81%12.68M71.22%3.51M147.06%3.49M333.14%3.06M936.76%2.62M--4.42M--2.05M--1.41M
Non-operating interest expense --0--0-55.00%540K--0--0-46.46%136K46.22%348K23.84%1.2M69.26%413K20.82%296K
Total other finance cost -------------------------26.32%56K-24.84%230K--00.00%77K
Other net income (expense) 99.73%-12K105.67%11K-117.48%-21.75M-69,363.16%-13.16M-16,516.67%-3.99M-88,220.00%-4.41M98.06%-194K-2,752.52%-10M-86.71%19K-117.14%-24K
Special income (charges) --0-----113.65%-21.37M---13.15M---4M---4.22M-------10M--0--0
-Less:Impairment of capital assets --0------16.37M--12.15M--0--4.22M------0--0--0
-Less:Other special charges ---------50.00%5M--1M--4M----------10M--0----
Other non- operating income (expenses) 93.55%-12K105.67%11K---383K---15K150.00%12K-3,820.00%-186K---194K---------117.14%-24K
Income before tax 3.57%-31.19M6.64%-28.06M-3.02%-134.79M-27.23%-40.27M-4.57%-32.13M-4.43%-32.34M19.84%-30.06M-36.60%-130.84M-12.43%-31.65M-18.13%-30.72M
Income tax -97.68%22K-99.92%1K1,967.03%1.88M-2,815.63%-869K2,268.00%592K5,177.78%950K7,450.00%1.21M111.63%91K32K25K
Net income 6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M-6.41%-32.72M-7.43%-33.29M16.66%-31.26M-36.64%-130.93M-12.37%-31.68M-18.22%-30.75M
Net income continuous Operations 6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M-6.41%-32.72M-7.43%-33.29M16.66%-31.26M-36.64%-130.93M-12.37%-31.68M-18.22%-30.75M
Minority interest income
Net income attributable to the parent company 6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M-6.41%-32.72M-7.43%-33.29M16.66%-31.26M-36.64%-130.93M-12.37%-31.68M-18.22%-30.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M-6.41%-32.72M-7.43%-33.29M16.66%-31.26M-36.64%-130.93M-12.37%-31.68M-18.22%-30.75M
Basic earnings per share 32.14%-0.3815.09%-0.45-1.32%-2.3-18.18%-0.65-3.77%-0.55-3.70%-0.5619.70%-0.5323.31%-2.27-7.30%-0.55-10.42%-0.53
Diluted earnings per share 32.14%-0.3815.09%-0.45-1.32%-2.3-18.18%-0.65-3.77%-0.55-3.70%-0.5619.70%-0.5323.31%-2.27-7.30%-0.55-10.42%-0.53
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data